SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Subjective Cognitive Complaints in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Siciliano, M; Tessitore, A; Morgante, F; Goldman, JG; Ricciardi, L (2024) Subjective Cognitive Complaints in Parkinson's Disease: A Systematic Review and Meta-Analysis. Mov Disord, 39 (1). pp. 17-28. ISSN 1531-8257 https://doi.org/10.1002/mds.29649
SGUL Authors: Morgante, Francesca

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (744kB) | Preview
[img]
Preview
PDF (Supplementary Material S1) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (67kB) | Preview
[img]
Preview
PDF (Supplementary Material S2) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (60kB) | Preview
[img]
Preview
PDF (Supplementary Material S3) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (88kB) | Preview
[img]
Preview
PDF (Supplementary Material S4) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (219kB) | Preview
[img]
Preview
PDF (Supplementary Material S5) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (88kB) | Preview
[img]
Preview
PDF (Supplementary Material S6) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (205kB) | Preview
[img]
Preview
PDF (Supplementary Material S7) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (86kB) | Preview
[img]
Preview
PDF (Supplementary Material S8) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (86kB) | Preview
[img]
Preview
PDF (Supplementary Material S9) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (86kB) | Preview
[img]
Preview
PDF (Supplementary Material S10) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (81kB) | Preview
[img]
Preview
PDF (Supplementary Material S11) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (87kB) | Preview
[img]
Preview
PDF (Supplementary Material S12) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (83kB) | Preview
[img]
Preview
PDF (Supplementary Material S13) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (88kB) | Preview
[img]
Preview
PDF (Supplementary Material S14) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (116kB) | Preview
[img]
Preview
PDF (Supplementary Material S15) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (159kB) | Preview
[img]
Preview
PDF (Supplementary Material S16) Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (48kB) | Preview

Abstract

BACKGROUND: Subjective cognitive complaints (SCCs) in Parkinson's disease (PD) are reported frequently, but their prevalence and association with changes on objective testing are not fully known. OBJECTIVE: We aimed to determine the prevalence, clinical correlates, and predictive value of SCCs in PD. METHODS: We conducted a systematic review and meta-analysis. From 204 abstracts, we selected 31 studies (n = 3441 patients), and from these, identified the prevalence, clinical features, associations with neuropsychiatric symptoms, and predictive values of SCCs in PD. RESULTS: The meta-analysis showed an SCC prevalence of 36%. This prevalence, however, was significantly moderated by study heterogeneity regarding female sex, disease severity, levodopa equivalent daily dosage, exclusion from the overall sample of patients with objective cognitive impairment, and measurement instrument. SCC prevalence did not differ between de novo and treated PD patients. SCCs were weakly and negligibly associated with cognitive changes on objective testing in cross-sectional studies. However, in cognitively healthy patients, SCCs had a risk ratio of 2.71 for later cognitive decline over a mean follow-up of 3.16 years. Moreover, SCCs were moderately related to co-occurring symptoms of depression, anxiety, or apathy and were more strongly related to these neuropsychiatric symptoms than objective cognitive functioning. CONCLUSION: Our analyses suggest that SCCs in patients with and without objective cognitive impairment are frequent, occurring in more than one third of PD patients. Establishing uniform measurement instruments for identifying PD-related SCCs is critical to understand their implications. Even in cases lacking evidence of objective cognitive impairment and where SCCs might reflect underlying neuropsychiatric symptoms, the possibility of later cognitive deterioration should not be excluded. Therefore, SCCs in PD patients warrant close monitoring for opportunities for targeted and effective interventions. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Item Type: Article
Additional Information: © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Keywords: Parkinson's disease, cognitive, mild cognitive impairment, nonmotor symptoms, subjective cognitive complaints, 1103 Clinical Sciences, 1106 Human Movement and Sports Sciences, 1109 Neurosciences, Neurology & Neurosurgery
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Mov Disord
ISSN: 1531-8257
Language: eng
Dates:
DateEvent
31 January 2024Published
3 January 2024Published Online
17 October 2023Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
PubMed ID: 38173220
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/116012
Publisher's version: https://doi.org/10.1002/mds.29649

Actions (login required)

Edit Item Edit Item